03-08-2023 09:59 AM | Source: ARETE Securities Ltd
Key Stock Ideas: Genesis, Jindal Stainless, Sun Pharma, Mercedes Benz India - ARETE Securities
News By Tags | #6763 #3564 #2063 #4104 #572 #999

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Genesis, IGL to invest Rs 110 cr to set up meter manufacturing plant:

Genesis, an arm of Vikas Lifecare Limited (VLF), has inked a pact with Indraprastha Gas Limited (IGL) to set up a meter manufacturing plant at an estimated cost of Rs 110 crore. The unit will be set up through a joint venture company, VLF said in a statement on Monday.Genesis Gas Solutions Pvt Ltd (Genesis) has entered into a JV agreement with IGL to set up a smart meter manufacturing plant with a capex of Rs 110 crore, it added.

Jindal Stainless to invest Rs 120 cr to set up two rooftop solar projects:

Jindal Stainless Ltd (JSL) on Tuesday said it will invest Rs 120 crore to set up rooftop solar capacities at its Jajpur and Hisar facilities. While a project of 21 megawatt peak (MWp) will be set up in Jajpur, another 6 MWp rooftop solar capacity will be installed at company's unit in Hisar, JSL said in a statement. "The two rooftop solar plants will be generating about 795 million units of electricity, with a carbon abatement potential of 5,64,450 tonnes in a span of 25 years," it said. Both the projects are scheduled to be completed by March 2024, the company said, adding that the energy generated will be for captive usage.

Sun Pharma completes acquisition of US-based Concert Pharmaceuticals:

Drug major Sun Pharma on Monday said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. The drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company that is developing deuruxolitinib for the potential treatment of adult patients with moderate to severe alopecia areata, Sun Pharma said in a regulatory filing.

Mercedes Benz India eyes double-digit growth in market share in 2023:

Mercedes Benz, India's largest luxury carmaker aims to achieve a double digit growth in market share this year, a top company official said on Monday.The company sold 15,822 cars last year, the highest in the luxury segment and achieved double digit growth, Mercedes-Benz India Vice President Sales and Marketing, Lance Bennett. Tamil Nadu was an important market for the vehicles in India, with 45 per cent growth, contributing 20 per cent to the pan India market and Coimbatore has showcased a robust 32 per cent year on year growth, Bennett said.

 

To Read Complete Report & Disclaimer Click Here

 

Please refer disclaimer at http://www.aretesecurities.com/
SEBI Regn. No.: INM000012740

 

Above views are of the author and not of the website kindly read disclaimer